Joseph Leveque, M.D.

Joe joined Mirati in 2020 as Chief Medical Officer, bringing nearly 30 years of healthcare, biopharmaceutical, and bioinformatics experience with extensive strategic leadership in advancing clinical development programs towards commercialization.

Prior to joining Mirati, Joe was Chief Medical Officer at Synthorx, a subsidiary of Sanofi, where he focused on therapeutic applications of synthetic biology in cancer and autoimmune disorders. He also served as the Chief Medical Officer at ARMO Biosciences, leading the development of cytokines for the treatment of cancer.

Earlier in his career, Joe was the Chief Medical Officer of EMD Serono, the U.S. and Canadian subsidiary of Merck KGaA. He also held key medical leadership roles, including Vice President and Head of U.S. Medical Oncology at Bristol Myers Squibb, specifically overseeing Yervoy* and Opdivo,* Vice President of Global Medical and Scientific Affairs at Onyx Pharmaceuticals, Vice President of Worldwide Medical and Scientific Affairs at Cephalon Oncology, and a Medical Director at Amgen.

Joe earned his M.D. from the University of Texas School of Medicine and completed his post-graduate medical training in internal medicine and critical care at the Cedars-Sinai Medical Center, a teaching affiliate of the University of California, Los Angeles. In addition, Joe holds an MBA from the Wharton School of the University of Pennsylvania and a B.S. degree in biology and mathematics from Santa Clara University.

* Trademarks are property of their respective owners.

About Cookies on This Site

This website uses cookies. Essential and functional cookies are necessary for the proper functioning of this website and cannot be refused. Other cookies are used for statistical purposes and will only be placed if you agree to their placement. For further details on cookies, how we use cookies and how to modify your choices regarding cookies, please read our Cookies Policy.